Why Compare Mounjaro V Wegovy Doses Privately?
Private Prescription Advantages for Mounjaro V Wegovy Doses
When comparing Mounjaro V Wegovy doses through private prescription, UK patients avoid the lengthy NHS route requiring GP referral to specialist weight management services. Private prescriptions provide immediate access to clinical assessment, with the same pharmaceutical-grade medications dispensed by GPhC-registered pharmacies like EverydayMeds (#9012878). Both medications require dose escalation protocols, but private prescription allows flexible timing and direct prescriber consultation.
The NHS typically restricts access to patients meeting strict BMI criteria with documented 6-month diet attempts, while private prescription focuses on clinical suitability for either Mounjaro or Wegovy doses. EverydayMeds provides transparent pricing for both options, helping patients understand the full cost commitment for their chosen weight management medication alongside a reduced-calorie diet and increased physical activity.
Mounjaro V Wegovy Doses: Pricing Comparison
Wegovy doses follow a structured escalation: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and 2.4mg maintenance (£209.99). New customers apply code FIRST40 at checkout, while returning customers use DOSE25 for these final prices. Bundle options like the Intro Duo (0.25mg & 0.5mg) cost £169.99, providing convenient two-month starter supply.
Mounjaro follows different dose escalation with varying private prescription costs across UK providers. When comparing Mounjaro V Wegovy doses financially, consider the full escalation journey rather than single pen prices. EverydayMeds' Ultimate Stability Trio provides three months of 2.4mg maintenance Wegovy for £649.99, offering supply security for patients established on their target dose.
Clinical Evidence Behind Mounjaro V Wegovy Doses
The STEP trials demonstrated Wegovy's efficacy across different doses, with patients achieving approximately 15% average weight loss at 68 weeks in STEP 1 (Wilding et al., NEJM, 2021). The escalation from 0.25mg to 2.4mg allows tolerance building while maintaining clinical effectiveness. These results occurred alongside intensive lifestyle interventions.
Mounjaro's SURMOUNT trials showed similar structured dose escalation benefits, though direct comparison between Mounjaro V Wegovy doses isn't appropriate due to different trial designs and patient populations. Both medications work through GLP-1 pathways, with Mounjaro additionally targeting GIP receptors as a dual agonist mechanism.
How Wegovy Doses Work in Your Body
Wegovy (semaglutide) mimics the natural GLP-1 hormone, binding to receptors in the brain's appetite centres and digestive system. Each escalating dose from 0.25mg to 2.4mg provides stronger appetite suppression and enhanced satiety signals after meals. The medication slows gastric emptying, helping you feel fuller for longer periods. Weekly injections maintain consistent blood levels, with higher doses providing more pronounced effects on food cravings. This mechanism works alongside dietary changes, not as a replacement for healthy eating habits.
Ordering Process for Mounjaro V Wegovy Doses
EverydayMeds' 3-minute online assessment covers medical history, current medications, and weight management goals relevant to both Mounjaro and Wegovy suitability. Qualified prescribers review your submission within 3 working days (or 24 hours with express service), determining appropriate medication and starting dose. Once approved, your chosen Wegovy dose ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirement. All orders include dosing instructions, injection technique guidance, and ongoing prescriber support for dose adjustments. The process requires no GP involvement, streamlining access to prescription-only weight management medication.
Storage Differences: Mounjaro V Wegovy Doses
Wegovy pens require refrigeration at 2-8°C before first use but tolerate room temperature (below 30°C) for up to 6 weeks once removed from the fridge. This provides significant travel advantages over Mounjaro's 21-day room temperature limit when comparing practical aspects of both medications. Each Wegovy dose comes in Novo Nordisk's FlexTouch pen, pre-filled and ready for subcutaneous injection. The 4-week dose escalation schedule from 0.25mg to maintenance requires careful planning, but the extended room temperature storage accommodates various lifestyles. Proper storage maintains medication potency across all dose strengths.
Dose Escalation Schedules: Mounjaro V Wegovy Comparison
Wegovy's fixed escalation cannot be modified: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance. This 16-week journey to full dose minimises side effects while building therapeutic effectiveness. Missing doses or jumping ahead isn't recommended and may increase gastrointestinal tolerability issues.
Mounjaro follows a different escalation timeline with alternative dose strengths, making direct comparison complex without individual clinical assessment. Private prescribers can discuss which medication's dose schedule better suits your tolerance levels, lifestyle commitments, and weight management timeline. Both require long-term commitment, as stopping either medication typically results in weight regain over subsequent months.
Private Prescription Access and Next Steps
EverydayMeds provides both Mounjaro and Wegovy through our GPhC-registered online pharmacy (#9012878), though current stock focuses on Wegovy's proven dose range from starter 0.25mg through 2.4mg maintenance. Your assigned prescriber reviews your clinical suitability for either medication, considering factors like diabetes status, previous weight loss attempts, and tolerance to GLP-1-based treatments. Express consultation options accommodate urgent prescription needs, while standard review maintains thorough safety assessment. Apply discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout for listed prices. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and discuss which medication suits your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
